Loading...
Loading...
Algernon Health Inc.
Algernon Health Inc.. Spoken Alpha tracks AGNPD's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks AGNPD's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 70% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for AGNPD.
curl https://api.spokenalpha.com/v1/companies/AGNPD| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.28 | $2.68 | +22.5% | -9.1% | -7.7% |
| Q4 FY2026 | $3.18 | $2.74 | +16.0% | -4.3% | -2.8% |
| Q3 FY2026 | $3.03 | $2.66 | +13.8% | -1.4% | +0.1% |
| Q2 FY2026 | $3.25 | $2.67 | +21.9% | -4.3% | -2.3% |
| Q1 FY2025 | $2.94 | $2.66 | +10.7% | -4.6% | -7.5% |
| Q4 FY2025 | $3.18 | $2.68 | +18.8% | +0.1% | -1.4% |
| Q3 FY2025 | $3.14 | $2.85 | +10.0% | -4.9% | -6.3% |
| Q2 FY2025 | $2.95 | $2.61 | +13.2% | +1.8% | +2.9% |
| Q1 FY2024 | $3.42 | $2.88 | +18.9% | -8.1% | -5.7% |
| Q4 FY2024 | $3.11 | $2.84 | +9.5% | +0.1% | +1.9% |